Vinay Prasad has stepped down as head of the FDA's Center for Biologics Evaluation and Research (CBER), less than three months after taking on the role. His departure – first reported by STAT and now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback